CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Insiders Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 21:00:03 28/07/2026 BST			5-day change	1st Jan Change
240.43 ^USD	+7.19%		+9.59%	+20.53%

07-20	Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix…
07-13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT

Insiders

07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
05-11	Charles River Laboratories International, Inc. Announces Board Elections	CI
02-18	Charles River Laboratories International, Inc. Announces Executive Appointments	CI
02-18	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
02-18	Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named	MT
01-12	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
01-12	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
01-08	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
01-08	Charles River Laboratories International, Inc. Announces Changes in Board	CI
01-08	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
01-08	Charles River Laboratories announces planned retirement of James C. Foster	RE
15/10/25	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI
16/09/25	Charles River Laboratories announces chief financial officer transition	RE
16/09/25	Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025	CI
16/09/25	Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition	CI
16/09/25	Charles River Laboratories Says CFO to Step Down	MT
07/05/25	Charles River to add new directors, review business in agreement with Elliott	RE
07/05/25	Charles River Laboratories International, Inc. Announces Board Changes	CI
12/11/24	Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing	MT
12/08/24	Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing	MT
04/03/24	Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing	MT
01/03/24	Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing	MT
24/01/24	Charles River Laboratories International, Inc. Appoints Reshema Kemps-Polanco to Board of Directors	CI
16/01/24	Charles River Laboratories International, Inc. Announces Executive Changes	CI
18/12/23	Charles River Laboratories International Insider Sold Shares Worth $1,243,350, According to a Recent SEC Filing	MT